INTRODUCTION
The changing patterns in the epidemiology of malaria worldwide have led inexorably to the spread of resistant strains of malaria parasites, and reduced efficacy to very vital antimalarial drugs such as chloroquine and sulfadoxine/pyrimethamine (1, 2) . The emergence of drug resistant malaria among countries in sub-Saharan Africa where the impact of malaria due to P. falciparum is most felt has created as dire necessity for constant surveillance and monitoring of P.
falciparum responses to the available antimalarial chemotherapies used in the region, using appropriate measures(3).
Constant monitoring is necessary in order to create a reliable national database which could be relied upon, to design and implement appropriate control measures aimed at preventing the wanton spread of multidrug resistance malaria within and across national borders.
In Nigeria, despite the importance of surveillance data to effective malaria control, the existing data on parasite susceptibility to several antimalarial drugs that are used in the country other than chloroquine are sparse. Only a few reports exist, particularly on the latter (4, 5, 6 
